Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
stent implantation · 1 trial · 1 indication
Evaluate the completeness of neointimal coverage following stent implantation (everolimus vs. zotarolimus-eluting stent) in patients with ACS. The degree of neointimal coverage will be assessed using optical coherence tomography (OCT) calculating the rate of exposed stent struts in the study stents.
| Arm | Type | Description |
|---|---|---|
| everolimus | ACTIVE_COMPARATOR | everolimus-eluting stent |
| zotarolimus | ACTIVE_COMPARATOR | zotarolimus-eluting stent |
| Name | Type | Description |
|---|---|---|
| stent implantation | DEVICE | implantation of everolimus-eluting stent vs zotarolimus-eluting stent |
Inclusion Criteria: * Diagnosis of ACS and clinical indication to PCI * Presence of 1 or more de novo stenosis equal or greater than 70% in native coronary arteries. * Patient is \> 18 years of age (or minimum age as required by local regulations). * The patient has consented to participate by sign...
Stent implantation is a procedure used in Acute Coronary Syndrome to open narrowed or blocked coronary arteries and restore blood flow to the heart. It involves placing a small mesh tube, called a stent, into the artery to keep it open. This treatment is being studied in a Phase 3 clinical trial.
Stent implantation is being developed by Cardio Diagnostics Holdings Inc., a company traded under the ticker CDIO. The company is conducting clinical research on this procedure for the treatment of Acute Coronary Syndrome.
Stent implantation is in Phase 3 clinical development. A Phase 3 trial has been completed, which studied the procedure in patients with Acute Coronary Syndrome. The trial was active-controlled and enrolled 60 participants.
Stent implantation has one completed clinical trial, NCT01239654, titled 'Activity of Platelets After Inhibition and Cardiovascular Events Optical Coherence Tomography Study'. This Phase 3 trial enrolled 60 patients with Acute Coronary Syndrome in Italy and was active-controlled.
Stent implantation is investigational and still in clinical development. It has not been reported as FDA approved. A Phase 3 clinical trial has been completed, but approval status has not been established.
Stent implantation works by physically opening a narrowed or blocked coronary artery and holding it open with a stent, a small mesh tube. This restores blood flow to the heart muscle. The procedure is being studied in patients with Acute Coronary Syndrome.